Global CRO to streamline content
management and training qualifications for greater
efficiency and transparency
BARCELONA, Spain, May 18, 2022 /PRNewswire/ -- Veeva
Systems (NYSE: VEEV) today announced that Simbec-Orion, a
full-service contract research organization (CRO), is using Veeva
Vault QualityDocs and Veeva Vault Training to simplify document
management and compliance training across quality assurance (QA).
By leveraging Veeva Vault Quality Suite applications on a single
platform, Simbec-Orion will improve visibility into quality
documentation and training requirements to ensure teams are up to
date on the latest industry standards. With this unified approach,
the company can gain high-quality data, drive faster execution, and
maintain compliance for its sponsors.
"We are continually advancing our digital framework to deliver
more efficiencies to our clients," said Jim
Kendall, chief information officer at Simbec-Orion. "Adding
Veeva Vault Quality Suite applications advances our controlled
document and training management, delivering specific process
improvements, such as policy, SOP, and WI authoring and essential
reading lists."
Simbec-Orion offers clinical trial management services in over
30 countries, specializing in clinical pharmacology, oncology, and
rare diseases. The addition of Vault QualityDocs and Vault Training
builds on the company's success with Veeva Vault Clinical Suite and
advances their digital transformation. Now Simbec-Orion will have
modern systems to enhance quality processes, facilitate training,
and ensure compliance.
"Veeva Vault QualityDocs and Veeva Vault Training empower our
teams with role-based access so they can easily see relationships
between processes to drive quality actions and workflows," said
Alison Hughes, head, business
enablement, Simbec-Orion. "Improving and simplifying procedures
like these makes us faster and more efficient while remaining
compliant."
"Simbec-Orion is committed to driving efficiency and speed
through digital execution and we're proud to support their efforts
with advanced quality systems," said Sofía Lange, director,
strategy, Veeva Vault Quality and manufacturing. "Veeva Vault
Quality Suite applications will help strengthen their QA processes
and drive quality and oversight across their operations."
Learn why more organizations are modernizing quality operations
on a single, unified platform at Veeva R&D and Quality Summit.
Life sciences industry professionals can register for the
in-person event in Zurich on June
8, 2022.
Additional Information
For more on Veeva Vault Quality
Suite, visit: veeva.com/eu/VaultQuality
Connect with Veeva on LinkedIn:
linkedin.com/company/veeva-systems
Follow @veeva_eu on Twitter: twitter.com/veeva_eu
About Simbec-Orion
Simbec-Orion is a responsive and
agile full-service CRO with specialist expertise in clinical
pharmacology, oncology, and rare diseases. Perfectly structured, we
provide full-service clinical development solutions for small and
mid-size drug developers – headed up by a centralized leadership
team. With a focus on tailormade and scalable solutions, we'll
adapt our delivery style, communications, and operations to suit
the demands of your project, helping you achieve your clinical and
commercial objectives. Because our goal is the same as yours; to
improve patients' lives. For more information,
visit simbecorion.com.
About Veeva Systems
Veeva is the global leader in
cloud software for the life sciences industry. Committed to
innovation, product excellence, and customer success, Veeva serves
more than 1,000 customers, ranging from the world's largest
pharmaceutical companies to emerging biotechs. As a Public Benefit
Corporation, Veeva is committed to balancing the interests of all
stakeholders, including customers, employees, shareholders, and the
industries it serves. For more information,
visit veeva.com/eu.
Veeva Forward-looking Statements
This release contains
forward-looking statements regarding Veeva's products and services
and the expected results or benefits from use of our products and
services. These statements are based on our current expectations.
Actual results could differ materially from those provided in this
release and we have no obligation to update such statements. There
are numerous risks that have the potential to negatively impact our
results, including the risks and uncertainties disclosed in our
filing on Form 10-K for the period ended January 31, 2022, which you can
find here (a summary of risks which may impact our
business can be found on pages 13 and 14), and in our subsequent
SEC filings, which you can access at sec.gov.
Contact:
|
|
|
|
Jeremy Whittaker
Veeva Systems
+49
6950955486 jeremy.whittaker@veeva.com
|
Deivis Mercado
Veeva Systems
+1-925-226-8821 deivis.mercado@veeva.com
|
Karen
McCusker
Simbec-Orion
+44 1753 578 080
karen.mccusker@simbecorion.com
|
|
Logo -
https://mma.prnewswire.com/media/1488285/Veeva_Systems_Logo.jpg